J. Wenkel

Statistics

Publications

Citations

H-Index

Active since

2003

Affiliations

Humboldt-Universität zu Berlin(Current)

Charité - Universitätsmedizin Berlin

Tel Aviv University

J. Wenkel is an author at Humboldt-Universität zu Berlin specializing in anticancer prodrug design, chemotherapeutic prodrug design, and tumor-targeted prodrugs.

Publications per year

2003–2003

Publications

Vaccination with minigenes encoding for novel ‘self’ antigens are effective in DNA-vaccination against neuroblastoma

Nicole Huebener, B. Lange, Claudia Lemmel et al. · Cancer Letters · 2003 · 31 citations

Pharmacy, Cancer Biology, Immunology +12

Hydrolytically activated etoposide prodrugs inhibit MDR-1 function and eradicate established MDR-1 multidrug-resistant T-cell leukemia

Ulrike Schröeder, Kathrin M. Bernt, Björn Lange et al. · Blood · 2003 · 21 citations · Full text

Medicine, Oncology, Pharmacology +11

Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma

B. Lange, Ulrike Schröeder, Nicole Huebener et al. · Cancer Letters · 2003 · 12 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Neuroblastoma directed therapy by a rational prodrug design of etoposide as a substrate for tyrosine hydroxylase

Marina Shamis, Nicole Huebener, Ulrike Schröeder et al. · Cancer Letters · 2003 · 11 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

1–4 of 4